Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 207

    1.

    World Antimalarial Resistance Network I: clinical efficacy of antimalarial drugs.

    Price RN, Dorsey G, Ashley EA, Barnes KI, Baird JK, d'Alessandro U, Guerin PJ, Laufer MK, Naidoo I, Nosten F, Olliaro P, Plowe CV, Ringwald P, Sibley CH, Stepniewska K, White NJ.

    Malar J. 2007 Sep 6;6:119.

    PMID:
    17822532
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    World Antimalarial Resistance Network (WARN) II: in vitro antimalarial drug susceptibility.

    Bacon DJ, Jambou R, Fandeur T, Le Bras J, Wongsrichanalai C, Fukuda MM, Ringwald P, Sibley CH, Kyle DE.

    Malar J. 2007 Sep 6;6:120.

    PMID:
    17822533
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    3.

    World Antimalarial Resistance Network (WARN) IV: clinical pharmacology.

    Barnes KI, Lindegardh N, Ogundahunsi O, Olliaro P, Plowe CV, Randrianarivelojosia M, Gbotosho GO, Watkins WM, Sibley CH, White NJ.

    Malar J. 2007 Sep 6;6:122.

    PMID:
    17822537
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    4.

    World Antimalarial Resistance Network (WARN) III: molecular markers for drug resistant malaria.

    Plowe CV, Roper C, Barnwell JW, Happi CT, Joshi HH, Mbacham W, Meshnick SR, Mugittu K, Naidoo I, Price RN, Shafer RW, Sibley CH, Sutherland CJ, Zimmerman PA, Rosenthal PJ.

    Malar J. 2007 Sep 6;6:121.

    PMID:
    17822535
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    5.

    The rationale and plan for creating a World Antimalarial Resistance Network (WARN).

    Sibley CH, Barnes KI, Plowe CV.

    Malar J. 2007 Sep 6;6:118.

    PMID:
    17822531
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    6.

    A network to monitor antimalarial drug resistance: a plan for moving forward.

    Sibley CH, Barnes KI, Watkins WM, Plowe CV.

    Trends Parasitol. 2008 Jan;24(1):43-8. Epub 2007 Nov 26. Review.

    PMID:
    18042432
    [PubMed - indexed for MEDLINE]
    7.

    [In vitro susceptibility of P. falciparum isolates from Abidjan (Côte d'Ivoire) to quinine, artesunate and chloroquine].

    Touré AO, Koné LP, Jambou R, Konan TD, Demba S, Beugre GE, Koné M.

    Sante. 2008 Jan-Mar;18(1):43-7. French.

    PMID:
    18684691
    [PubMed - indexed for MEDLINE]
    Free Article
    8.

    Current status of malaria chemotherapy and the role of pharmacology in antimalarial drug research and development.

    Na-Bangchang K, Karbwang J.

    Fundam Clin Pharmacol. 2009 Aug;23(4):387-409. Review.

    PMID:
    19709319
    [PubMed - indexed for MEDLINE]
    9.

    Antimalarial drugs: current status and new developments.

    Rathore D, McCutchan TF, Sullivan M, Kumar S.

    Expert Opin Investig Drugs. 2005 Jul;14(7):871-83. Review.

    PMID:
    16022576
    [PubMed - indexed for MEDLINE]
    10.

    Assessment of safety of the major antimalarial drugs.

    Chattopadhyay R, Mahajan B, Kumar S.

    Expert Opin Drug Saf. 2007 Sep;6(5):505-21. Review.

    PMID:
    17877439
    [PubMed - indexed for MEDLINE]
    11.

    Monitoring antimalarial resistance: launching a cooperative effort.

    Sibley CH, Guerin PJ, Ringwald P.

    Trends Parasitol. 2010 May;26(5):221-4. Epub 2010 Mar 20.

    PMID:
    20304706
    [PubMed - indexed for MEDLINE]
    12.

    Responding to the challenge of antimalarial drug resistance by routine monitoring to update national malaria treatment policies.

    Vestergaard LS, Ringwald P.

    Am J Trop Med Hyg. 2007 Dec;77(6 Suppl):153-9. Review.

    PMID:
    18165488
    [PubMed - indexed for MEDLINE]
    Free Article
    13.

    Mekong malaria. II. Update of malaria, multi-drug resistance and economic development in the Mekong region of Southeast Asia.

    Socheat D, Denis MB, Fandeur T, Zhang Z, Yang H, Xu J, Zhou X, Phompida S, Phetsouvanh R, Lwin S, Lin K, Win T, Than SW, Htut Y, Prajakwong S, Rojanawatsirivet C, Tipmontree R, Vijaykadga S, Konchom S, Cong le D, Thien NT, Thuan le K, Ringwald P, Schapira A, Christophel E, Palmer K, Arbani PR, Prasittisuk C, Rastogi R, Monti F, Urbani C, Tsuyuoka R, Hoyer S, Otega L, Thimasarn K, Songcharoen S, Meert JP, Gay F, Crissman L, Cho-Min-Naing, Chansuda W, Darasri D, Indaratna K, Singhasivanon P, Chuprapawan S, Looareesuwan S, Supavej S, Kidson C, Baimai V, Yimsamran S, Buchachart K.

    Southeast Asian J Trop Med Public Health. 2003;34 Suppl 4:1-102.

    PMID:
    15906747
    [PubMed - indexed for MEDLINE]
    14.

    [Current antimalarial drugs: resistance and new strategies].

    Ringwald P.

    Bull Acad Natl Med. 2007 Oct;191(7):1273-84; discussion 1284. Review. French.

    PMID:
    18447049
    [PubMed - indexed for MEDLINE]
    15.

    The fight against drug-resistant malaria: novel plasmodial targets and antimalarial drugs.

    Choi SR, Mukherjee P, Avery MA.

    Curr Med Chem. 2008;15(2):161-71. Review.

    PMID:
    18220771
    [PubMed - indexed for MEDLINE]
    16.

    Assessment of the efficacy of antimalarial drugs recommended by the National Malaria Control Programme in Madagascar: up-dated baseline data from randomized and multi-site clinical trials.

    Ménard D, Ratsimbasoa A, Randrianarivelojosia M, Rabarijaona LP, Raharimalala L, Domarle O, Randrianasolo L, Randriamanantena A, Jahevitra M, Andriantsoanirina V, Rason MA, Raherinjafy R, Rakotomalala E, Tuseo L, Raveloson A.

    Malar J. 2008 Apr 4;7:55.

    PMID:
    18394169
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    17.

    Spread of anti-malarial drug resistance: mathematical model with implications for ACT drug policies.

    Pongtavornpinyo W, Yeung S, Hastings IM, Dondorp AM, Day NP, White NJ.

    Malar J. 2008 Nov 2;7:229.

    PMID:
    18976503
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    18.

    Simplified antimalarial therapeutic monitoring: using the day-7 drug level?

    White NJ, Stepniewska K, Barnes K, Price RN, Simpson J.

    Trends Parasitol. 2008 Apr;24(4):159-63. Epub 2008 Mar 19.

    PMID:
    18353727
    [PubMed - indexed for MEDLINE]
    19.

    Monitoring and deterring drug-resistant malaria in the era of combination therapy.

    Laufer MK, Djimdé AA, Plowe CV.

    Am J Trop Med Hyg. 2007 Dec;77(6 Suppl):160-9. Review.

    PMID:
    18165489
    [PubMed - indexed for MEDLINE]
    Free Article
    20.

    Modulators of the efficacy and toxicity of drugs in malaria treatment.

    Nzila A, Chilengi R.

    Trends Pharmacol Sci. 2010 Jun;31(6):277-83. Epub 2010 Apr 9. Review.

    PMID:
    20381886
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk